Ingineeon Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Ingineeon General Information
Description
Developer of advanced cytokine-based immunotherapeutics based in Munich, Germany. The company's immunotherapeutics comprise first-in-class biologics in infectious diseases, inflammatory diseases and oncology, enabling the healthcare sector to bring breakthrough medical innovations to patients.
Contact Information
Website
www.ingineeon.comCorporate Office
- Neherstraße 1
- 81675 Munich
- Germany
Corporate Office
- Neherstraße 1
- 81675 Munich
- Germany
Ingineeon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2024 | Completed | Startup |
Ingineeon Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Technical University of Munich | University | |||
| MAxL | Accelerator/Incubator |
Ingineeon FAQs
-
When was Ingineeon founded?
Ingineeon was founded in 2024.
-
Where is Ingineeon headquartered?
Ingineeon is headquartered in Munich, Germany.
-
What industry is Ingineeon in?
Ingineeon’s primary industry is Drug Discovery.
-
Is Ingineeon a private or public company?
Ingineeon is a Private company.
-
What is Ingineeon’s current revenue?
The current revenue for Ingineeon is .
-
Who are Ingineeon’s investors?
Technical University of Munich and MAxL have invested in Ingineeon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
